St. Jude To Bring All Devices Under One Roof
This article was originally published in The Gray Sheet
St. Jude Medical plans to combine its implantable electronic device unit with its cardiovascular/ablation unit into one integrated R&D organization, and announced several senior leadership changes as part of the restructuring.
You may also be interested in...
St. Jude Makes Change At The Top
Daniel Starks is retiring as CEO of St. Jude Medical while Chief Operating Officer Michael Rousseau prepares to take the top spot on Jan. 1.
St. Jude Restructuring Will Cut 300 Jobs, Save Up To $60 Million In 2013
Move will realign four product divisions into two new operating units to support growth opportunities, help offset impact of 2.3% device tax set to take effect next year.
Finance Watch: LSP Dementia Fund Closes With €260m For Neurodegenerative Diseases
EQT Life Sciences completed the final close of its inaugural LSP Dementia Fund, far surpassing an initial $100m fundraising goal. Also, Resilience received a $410m commitment from the Department of Defense to fund biomanufacturing and Viking cashed in on Phase I obesity data with a $250m offering.